ArticleEmerging infectious diseases2018

Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada.

Salaheddin M Mahmud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.